Neoplasms

Symptoms and General Pathology

All Conditions

Urinary Tract, Sexual Organs, and Pregnancy Conditions

Rare Diseases

Neoplasm Metastasis

Carcinoma, Renal Cell

Kidney Neoplasms

Carcinoma

Urologic Neoplasms

Urogenital Neoplasms

Urogenital Diseases

Female Urogenital Diseases

Pregnancy Complications

Female Urogenital Diseases and Pregnancy Complications

Kidney Diseases

Urologic Diseases

Male Urogenital Diseases

Adenocarcinoma

Neoplasms, Glandular and Epithelial

Neoplasms by Histologic Type

Renal Cell Carcinoma

All Drugs and Chemicals

Vaccines

Immunomodulating Agents

Immunologic Factors

In this group, the patients will receive mix vaccine. The check indexes are image examination (CT, MRI or PET scan) and blood tests (including tumor markers, lymphocyte subsets and circulating tumor cell).

In this group, the patients will receive no special treatment and as a control group. The check indexes are image examination (CT, MRI or PET scan) and blood tests (including tumor markers, lymphocyte subsets and circulating tumor cell).

Each treatment: 0.5 ml /week, Subcutaneous injection of the deltoid muscle

Mix vaccine

The aim of this study is the safety and efficacy of mix vaccine to small metastases of kidney cancer.

By enrolling patients with small metastases of kidney cancer adapted to enrolled criteria, this study will document for the first time the safety and the short and long term efficacy of mix vaccine.

The safety will be evaluated by statistics of adverse reactions. The efficacy will be evaluated according to local relief degree, progress free survival (PFS) and overall survival (OS).

Mix Vaccine for Metastatic Kidney Cancer

Safety and Efficacy Study of Mix Vaccine in Kidney Cancer Patient

It will be evaluated by the Response Evaluation Criteria in Solid Tumors（RECIST）

The duration from the beginning of treatment to cancer recurrence or progression

The duration from the beginning of treatment to patient death

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Mix Vaccine for Metastatic Kidney Cancer	NCT03357289	Metastasis From... Reaction - Mixe...	Mix vaccine	40 Years - 70 Years	Fuda Cancer Hospital, Guangzhou
Mix Vaccine for Metastatic Kidney Cancer	NCT03357289	Metastasis From... Reaction - Mixe...	Mix vaccine	40 Years - 70 Years	Fuda Cancer Hospital, Guangzhou

Spots Global Cancer Trial Database for metastasis from malignant tumor of kidney (disorder)